6532 |
SOLUTE CARRIER FAMILY 6 MEMBER 4 |
SLC6A4 |
5-HTT |
5-HTTLPR |
5HTT |
HTT |
OCD1 |
SERT |
SERT1 |
hSERT |
182138 |
11050 |
ENSG00000108576 |
OTTHUMG00000132751 |
P31645 |
SODIUM-DEPENDENT SEROTONIN TRANSPORTER (5HT TRANSPORTER) (5HTT). [SOURCE:UNIPROT/SWISSPROT;ACC:P31645] |
SC6A4_HUMAN |
SODIUM-DEPENDENT SEROTONIN TRANSPORTER |
PA312 |
5HT transporter |
Human Readable Name | DRUGGABLE GENOME |
Uniprot Evidence | 1: Evidence at protein level |
Interpro Type | Family |
Interpro Short Name | Na/ntran_symport |
Interpro Name | Sodium:neurotransmitter symporter |
Uniprot Status | Swiss-Prot |
Interpro Acc | IPR000175 |
Human Readable Name | TRANSPORTER |
Target Class | Transporters |
Target Subclass | TC:2.A.22.1.1 |
Target Class | Transporter |
Target Subclass | Other |
Transmembrane Helix Count | 12 |
Target Subclass | SLC |
Target Subclass | SLC6 |
Target Main Class | Transporters |
Gene Biotype | PROTEIN_CODING |
TRANSPORTER |
DRUGGABLE GENOME |
inhibitor (inhibitory) |
Trial Name | sibutramine HCl monohydrate,Meridia, Reductil, Reduxade, Zelium |
Novel drug target | Established target |
inhibitor (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
inhibitor (inhibitory) |
Trial Name | Milnacipran |
Novel drug target | Established target |
n/a |
Trial Name | tesofensine, NS-2330 |
Novel drug target | Established target |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | - |
n/a |
Trial Name | YKP-10A |
Novel drug target | Established target |
inhibitor (inhibitory) |
Trial Name | dapoxetine,Priligy |
Novel drug target | Established target |
inhibitor (inhibitory) |
Trial Name | levomilnacipran, F2695 |
Novel drug target | Established target |
inhibitor (inhibitory) |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
Trial Name | NPL-2008, Fluoxetine |
Trial Name | fluoxetine HCl,Prozac |
inhibitor (inhibitory) |
Trial Name | ITI-007, ITI-722 |
Novel drug target | Established target |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | Lu AA21004 |
inhibitor (inhibitory) |
Trial Name | trazodone extended release, DDS-04A,Oleptro |
Novel drug target | Established target |
inhibitor (inhibitory) |
Trial Name | CRx-150, amoxapine plus dipyridamole |
Novel drug target | Established target |
Trial Name | CRx-119 |
inhibitor (inhibitory) |
Trial Name | doxepin nasal solution,Dolorac |
Novel drug target | Established target |
Trial Name | Silenor (SO-101) |
negative modulator (inhibitory) |
Trial Name | low dose intravenous methamphetamine |
Novel drug target | Established target |
inhibitor (inhibitory) |
Trial Name | fexofenadine + ps/ |
Novel drug target | Established target |
inhibitor (inhibitory) |
Trial Name | methylphenidate HCl,Concerta |
Novel drug target | Established target |
Trial Name | methylphenidate HCl,Metadate CD, Equasym |
n/a |
Trial Name | Lu AA24530 |
Novel drug target | Established target |
SLC6A4 | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
SODIUM-DEPENDENT SEROTONIN TRANSPORTER (5HT TRANSPORTER) (5HTT). [SOURCE:UNIPROT/SWISSPROT;ACC:P31645] | Description |
SLC6A4 | Display Id |
ENSG00000108576 | Ensembl Gene Id |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
6532 | Entrez Gene Id |
P31645 | Uniprot Accession |
SODIUM-DEPENDENT SEROTONIN TRANSPORTER | Uniprot Protein Name |
Uniprot Evidence | 1: Evidence at protein level |
Interpro Type | Family |
Interpro Short Name | Na/ntran_symport |
TRANSPORTER, DRUGGABLE GENOME |
SLC6A4 | Gene Symbol |
Target Class | Transporters |
Target Subclass | TC:2.A.22.1.1 |
Target Class | Transporter |
SC6A4_HUMAN | Uniprot Id |
SLC6A4 | Gene Symbol |
P31645 | Uniprot Accession |
Target Subclass | Other |
Transmembrane Helix Count | 12 |
Target Subclass | SLC |
PA312 | PharmGKB ID |
ENSG00000108576 | Gene Symbol |
SLC6A4 | Ensembl Id |
DRUGGABLE GENOME |
Sodium-dependent serotonin transporter | Gene Name |
P31645 | UniProt ID |
TRANSPORTER |